144 / 172
144
19. Clark P, Casas E, Tugwell P, Medina C, Gheno C, Tenorio
G, et al. Hydroxychloroquine compared with placebo in
rheumatoid arthritis: a randomized controlled trial. Ann Intern
Med 1993;119:1067–71.
20. A randomized trial of hydroxychloroquine in early
rheumatoid arthritis: the HERA study. Am J Med 1995;98:156-
68.
21. Suarez-Almazor ME, Belseck E, Shea B, Homik J, Wells G,
Tugwell P. Antimalarials for treating rheumatoid arthritis.
Cochrane Database Syst Rev 2000;(4):CD000959.
22. Rau R, Herborn G, Menninger H, Sangha O. Radiographic
outcome after three years of patients with early erosive
rheumatoid arthritis treated with intramuscular methotrexate
or parenteral gold. Extension of a one-year double-blind study
in 174 patients. Rheumatology (Oxford) 2002;41:196-204.
23.
Lehman AJ, Esdaile JM, Klinkhoff AV, Grant E, Fitzgerald A, Canvin J; METGO Study Group.A 48-week, randomized,
double-blind, double-observer, placebo-controlled multicenter
trial of combination methotrexate and intramuscular gold
therapy in rheumatoid arthritis: results of the METGO study.
Arthritis Rheum2005;52:1360-70.
24. Genovese MC, Cohen S, Moreland L, Lium D, Robbins S,
Newmark R, et al. Combination therapy with etanercept and
anakinra in the treatment of patients with rheumatoid arthritis
who have been treated unsuccessfully with methotrexate.
Arthritis Rheum 2004;50:1412-9.
25.Weinblatt M, Combe B, Covucci A, Aranda R, Becker JC,
Keystone E. Safety of the selective costimulation modulator
abatacept in rheumatoid arthritis patients receiving
background biologic and nonbiologic disease-modifying
antirheumatic drugs: A one-year randomized, placebo-
controlled study. Arthritis Rheum 2006;54:2807-16.
26.Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF,
van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and